[Pheochromocytoma].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D006801:Humans; D008781:Methyltyrosines / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000188:drug therapy / Q000628:therapy*
D000317:Adrenergic alpha-Antagonists; D008781:Methyltyrosines